Nutritional status is a prognostic factor for survival in ALS patients

Neurology

Volumn 53, Issue 5, 1999, Pages 1059-1063

  Desport, J C ^b   Preux, P M ^a   Truong, T C ^c   Vallat, J M ^c   Sautereau, D ^c   Couratier, P ^c  

^a Faculté de Médecine   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

^c NONE

Author keywords

ALS; Motor neuron disease; Nutrition; Prognosis

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NUTRITIONAL STATUS; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; VITAL CAPACITY;

EID: 0033595524     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.5.1059     Document Type: Article

References (29)

1. Lee JR-J, Annegers JF, Appel SH. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 1995;132:207-215.
2. Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr 1996;63:130-137.
3. Depaul R, Abbs JH. Manifestations of ALS in the cranial motor nerves. Dynametric, neuropathologic, and speech motor data. Neurol Clin 1987;5:231-250.
4. Norris FH, Shepherd R, Denys E, et al. Onset, natural history and outcome in idiopathic adult motor neurone disease. J Neurol Sci 1993;118:48-55.
5. Robbins J. Swallowing in ALS and motor neurone disorders. Neurol Clin 1987;5:213-229.
6. Slowie LA, Paige MS, Antel JP. Nutritional considerations in the management of patients with amyotrophic lateral sclerosis (ALS). J Am Diet Assoc 1983;83:44-47.
7. Subcommittee on Motor Neurone Disease/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases, El Escorial Clinical Limits of Amyotrophic Lateral Sclerosis Workshop contributors. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994; 124(suppl):96-107.
8. Andersen PK, Keiding N. Survival analysis, overview. In: Armitage P, Colton T, ed. Encyclopedia of biostatistics. Chichester, UK: Wiley, 1998:4452-4461.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
10. Aid to the investigation of peripheral nerve injuries. In: Medical Research Council, ed. War memorandum, 2nd ed., revised. London: His Majesty's Stationery Office, 1943:11-46.
11. Norris FH Jr. Charting the course in amyotrophic lateral sclerosis. In: Rose FC, ed. Amyotrophic lateral sclerosis. New York: Demos, 1990:83-92.
12. The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. The Amyotrophic Lateral Sclerosis Functional Rating Scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996;53:141-147.
13. Bensimon G, Lacomblez L, Meininger V, the ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994;330:585-591.
14. Torun B, Chew F. Protein-energy malnutrition. In: Shils ME, Olson JA, Shike M, eds. Modern nutrition in health and disease. 8th ed., vol. II. Philadelphia: Lea & Febiger, 1993:959-960.
15. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972;34:187-220.
16. Mazzini L, Corra T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 1995;242:695-698.
17. Nau KL, Bromberg MB, Forshew DA, Katch VL. Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci 1995;129(suppl):47-49.
18. Shimizu T, Hayashi H, Tanabe H. Energy metabolism of ALS patients under mechanical ventilation and tube feeding. Clin Neurol 1991;31:255-259.
19. Scarpa M, Colombo A, Panzetti P, Sorgato P. Epidemiology of amyotrophic lateral sclerosis in the province of Modena, Italy. Influence of environmental exposure to lead. Acta Neurol Scand 1988;77:456-460.
20. Leigh PN, Ray-Chaudhuri K. Motor neurone disease. J Neurol Neurosurg Psychiatry 1994;57:886-896.
21. Preux PM, Couratier P, Boutros-Toni F, et al. Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors. Neuroepidemiology 1996;15:153-160.
22. Chazot F, Vallat JM, Hugon J, Lubeau M, Dumas M. Amyotrophic lateral sclerosis in Limousin. Neuroepidemiology 1986;5:39-46.
23. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival predication. Brain 1995;118:707-719.
24. James WPT, Ferro-Luzzi A, Waterlow JC. Definition of chronic energy deficiency in adults. Eur J Clin Nutr 1988;42: 969-981.
25. Kasarskis EJ, Neville HE. Management of ALS: nutritional care. Neurology 1996;47(suppl 2):S118-S120.
26. Ringel SP, Murphy JR, Alderson MK, et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993;40: 1316-1322.
27. Treatment trials. In: Mitsumoto H, Chad DA, Pioro EP, eds. Amyotrophic lateral sclerosis; contemporary neurology series. Philadelphia: FA Davis, 1998:329-359.
28. The ALS CNTF Treatment Study (ACTS) Group. Prognostic indicators of survival in amyotrophic lateral sclerosis. Neurology 1996;46:A208. Abstract.
29. Jeejeebhoy KN. Muscle function and nutrition. Gut 1986; 27(suppl 1):25-39.